Exact Mass: 511.147839

Exact Mass Matches: 511.147839

Found 26 metabolites which its exact mass value is equals to given mass value 511.147839, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(+)-Indocarbazostatin

(+)-Indocarbazostatin

C28H21N3O7 (511.1379436)


   

Cys Cys Thr Trp

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanoic acid

C21H29N5O6S2 (511.1559174)


   

Cys Cys Trp Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanoic acid

C21H29N5O6S2 (511.1559174)


   

Cys Thr Cys Trp

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C21H29N5O6S2 (511.1559174)


   

Cys Thr Trp Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559174)


   

Cys Trp Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C21H29N5O6S2 (511.1559174)


   

Cys Trp Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559174)


   

Thr Cys Cys Trp

(2S)-2-[(2R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C21H29N5O6S2 (511.1559174)


   

Thr Cys Trp Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559174)


   

Thr Trp Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559174)


   

Trp Cys Cys Thr

(2S,3R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C21H29N5O6S2 (511.1559174)


   

Trp Cys Thr Cys

(2R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559174)


   

Trp Thr Cys Cys

(2R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559174)


   
   
   
   

(2-Amino-2-biphenylyl)(chloro)palladium - tris(2-methyl-2-propanyl)phosphine (1:1)

(2-Amino-2-biphenylyl)(chloro)palladium - tris(2-methyl-2-propanyl)phosphine (1:1)

C24H37ClNPPd (511.1386752000001)


   
   

PPTN (hydrochloride)

PPTN (hydrochloride)

C29H25ClF3NO2 (511.1525816)


PPTN hydrochloride is a potent, high-affinity, competitive and highly selective P2Y14 receptor antagonist with a KB value of 434 pM. PPTN hydrochloride exhibits no agonist or antagonist effect at the P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, or P2Y13 receptors. Anti-inflammatory and anti-immune activity[1].

   

(5s,7r,8s,9r,10r,18r)-18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone

(5s,7r,8s,9r,10r,18r)-18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone

C26H25NO10 (511.147839)


   

1-[5-({[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyimidazole-4-carboxylic acid

1-[5-({[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyimidazole-4-carboxylic acid

C20H25N5O11 (511.15504999999996)


   

ethyl (15r,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

ethyl (15r,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

C28H21N3O7 (511.1379436)


   

ethyl (15s,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

ethyl (15s,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

C28H21N3O7 (511.1379436)


   

1-[(2r,3r,4s,5r)-5-[(s)-{[(2s,3s,4r)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}(carboxy)methyl]-3,4-dihydroxyoxolan-2-yl]-2-hydroxyimidazole-4-carboxylic acid

1-[(2r,3r,4s,5r)-5-[(s)-{[(2s,3s,4r)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}(carboxy)methyl]-3,4-dihydroxyoxolan-2-yl]-2-hydroxyimidazole-4-carboxylic acid

C20H25N5O11 (511.15504999999996)


   

18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone

18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone

C26H25NO10 (511.147839)